XEN-101

N/A

Report date: 2022/12/30 20:00:49
NME

Base Information

Drug NameXEN-101
Drug Alias NameXEN-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungaryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXeno Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesXeno Biosciences Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A